Susquehanna International Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-103,100
| Closed | -$3.96M | – | 13422 |
|
|
2023
Q2 | $3.96M | Buy |
+103,100
| New | +$2.65M | ﹤0.01% | 3904 |
|
|
2023
Q1 | – | Sell |
-9,400
| Closed | -$246K | – | 13921 |
|
|
2022
Q4 | $246K | Buy |
+9,400
| New | +$208K | ﹤0.01% | 9597 |
|
|
2021
Q3 | – | Sell |
-16,300
| Closed | -$230K | – | 13842 |
|
|
2021
Q2 | $230K | Sell |
16,300
-1,200
| -7% | -$19.2K | ﹤0.01% | 11304 |
|
|
2021
Q1 | $272K | Sell |
17,500
-2,100
| -11% | -$34.2K | ﹤0.01% | 10812 |
|
|
2020
Q4 | $311K | Buy |
+19,600
| New | +$296K | ﹤0.01% | 9184 |
|
|
2018
Q4 | – | Sell |
-19,380
| Closed | -$712K | – | 10239 |
|
|
2018
Q3 | $712K | Buy |
19,380
+13,780
| +246% | +$442K | ﹤0.01% | 5902 |
|
|
2018
Q2 | $196K | Buy |
5,600
+2,740
| +96% | +$105K | ﹤0.01% | 8626 |
|
|
2018
Q1 | $133K | Sell |
2,860
-300
| -9% | -$11K | ﹤0.01% | 8588 |
|
|
2017
Q4 | $119K | Buy |
3,160
+1,120
| +55% | +$48.9K | ﹤0.01% | 8621 |
|
|
2017
Q3 | $109K | Sell |
2,040
-20
| -1% | -$1.19K | ﹤0.01% | 8328 |
|
|
2017
Q2 | $117K | Sell |
2,060
-1,080
| -34% | -$54.2K | ﹤0.01% | 8613 |
|
|
2017
Q1 | $169K | Sell |
3,140
-3,720
| -54% | -$210K | ﹤0.01% | 8131 |
|
|
2016
Q4 | $391K | Sell |
6,860
-1,040
| -13% | -$62.9K | ﹤0.01% | 7462 |
|
|
2016
Q3 | $491K | Buy |
7,900
+1,960
| +33% | +$139K | ﹤0.01% | 6086 |
|
|
2016
Q2 | $336K | Buy |
5,940
+1,100
| +23% | +$66.8K | ﹤0.01% | 6775 |
|
|
2016
Q1 | $310K | Buy |
4,840
+1,300
| +37% | +$105K | ﹤0.01% | 7212 |
|
|
2015
Q4 | $498K | Buy |
3,540
+1,160
| +49% | +$158K | ﹤0.01% | 6777 |
|
|
2015
Q3 | $231K | Buy |
2,380
+920
| +63% | +$110K | ﹤0.01% | 8489 |
|
|
2015
Q2 | $221K | Buy |
+1,460
| New | +$241K | ﹤0.01% | 9118 |
|
Susquehanna International Group's KDNY Position: Q3 2023 in Review
Susquehanna International Group sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 156,194 shares — an estimated $6M sold.
Susquehanna International Group first reported a position in KDNY in Q2 2015 and held it in 20 quarters. The position peaked at $6M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Susquehanna International Group reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 156,194 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6M.
- Susquehanna International Group first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 20 quarters.
- Susquehanna International Group's Chinook Therapeutics, Inc. Common Stock position peaked at $6M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.